bluebird bio (BLUE)
(Delayed Data from NSDQ)
$1.11 USD
+0.03 (2.78%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.11 0.00 (0.00%) 6:52 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For BLUE
-
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
-
bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
-
bluebird (BLUE) Misses on Q4 Revenues, Provides Portfolio Updates
-
Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
-
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
-
Bluebird (BLUE) Up 48.2% Since Last Earnings Report: Can It Continue?
-
bluebird (BLUE) Q3 Earnings Top; Zynteglo, Skysona Fuel Sales
-
Bluebird: Q3 Earnings Snapshot
-
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
-
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Bluebird (BLUE) Up 7.3% Since Last Earnings Report: Can It Continue?
-
bluebird (BLUE) Q2 Earnings Top, Zynteglo & Skysona Fuel Revenues
-
Bluebird Bio (BLUE) Reports Q2 Loss, Misses Revenue Estimates
-
Bluebird: Q2 Earnings Snapshot
-
bluebird bio Reports Second Quarter 2023 Financial Results and Highlights Operational Progress
-
Bluebird (BLUE) Down 26% Since Last Earnings Report: Can It Rebound?
-
bluebird (BLUE) Posts Q1 Earnings, Focuses on Zynteglo, Skysona
-
Bluebird Bio (BLUE) Q1 Earnings Surpass Estimates
-
Bluebird: Q1 Earnings Snapshot
-
bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational Progress
-
Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Why Is Bluebird (BLUE) Up 17.2% Since Last Earnings Report?
-
bluebird (BLUE) Down on Updates on SCD Therapy, Reports Q4
-
Bluebird: Q4 Earnings Snapshot
-
Bluebird Bio (BLUE) Reports Q4 Loss, Misses Revenue Estimates